Bath & Body Works

BBWI · NYSE · Consumer Discretionary · Financials, fiscal 2016 to 2025

BBWI · Last close · October 26, 2026

$21.38

Bath & Body Works' revenue fell 0.2% to $7.3 billion in fiscal 2025. Its operating margin was 15.4%, down from 17.3% a year earlier. Free cash flow was $865 million, up 31.1%. It paid out $568 million in dividends and buybacks, 66% of free cash flow. The diluted share count fell 5.4%.

BATH & BODY WORKS, INC. Latest fiscal year ended January 31, 2026 10-K filed March 12, 2026 · 0000701985-26-000008 Updated October 9, 2026

Revenue

$7.3B

0.2%

Operating margin

15.4%

1.9 pts

Net income

$649M

18.7%

Free cash flow

$865M

31.1%

Return on capital

47.5%

8.6 pts

Market cap

$4.3B

Oct 26 close

P/E

5.6x

On $3.79 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

Revenue and margins

Revenue

US$ billions, fiscal years

Margins

Percent of revenue

GrossOperatingNetFree cash flow

Net income and earnings per share

From fiscal 2016 to 2025, earnings per share fell 2.7% a year and net income 6.2% a year, while buybacks cut the share count by 28%.

Net income

US$ billions, fiscal years; loss years in red.

Diluted earnings per share

US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity

Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.

Return on capitalReturn on equity

Cash flow

Free cash flow

US$ billions. Cash from operations minus capital expenditure; negative years in red.

Payouts and share count

Dividends and buybacks

US$ billions, cash paid in each fiscal year

DividendsShare buybacks

Diluted share count

Weighted-average diluted shares, millions

Valuation

Two ways to value Bath & Body Works yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.

What Bath & Body Works says to expect

Third quarter 2026: net sales and earnings per shareFor the third quarter of 2026, the company is forecasting net sales to decline between 5% to 2.5% compared to $1,594 million in the third quarter of 2025. Third quarter 2026 earnings per diluted share is expected to be between $0.05 and $0.10, compared to earnings per diluted share of $0.37 in the third quarter of 2025 and third quarter 2026 adjusted earnings per diluted share is expected to be between $0.07 and $0.12 compared to adjusted earnings per diluted share of $0.35 in the third quarter of 2025.
Full year 2026: net salesThe company is narrowing its full-year 2026 guidance of net sales to decline between 4% to 2.5% compared to $7,291 million in fiscal 2025.
Full year 2026: earnings per shareThe company is also raising its full-year 2026 earnings per diluted share guidance to between $3.13 and $3.33 compared to $3.11 in fiscal 2025 and full-year 2026 adjusted earnings per diluted share guidance to between $2.60 and $2.80, compared to adjusted earnings per diluted share of $3.21 in 2025.
Full year 2026: free cash flowIn fiscal 2026, we now expect to generate free cash flow of approximately $650 million.

The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed August 26, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Discounted cash flow (DCF)

A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Bath & Body Works' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.

Value per share on three example scenarios, from Bath & Body Works' fiscal 2025 free cash flow of $865M, net cash of −$2.9B at January 31, 2026 and 209 million diluted shares, from its filings. The scenarios are fitted to Bath & Body Works: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -1.2% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 11%: 9% for a business of moderate risk (Other Specialty Retail), plus 1 point as a smaller company, worth $4.3B, plus 1 point for unsteady results (revenue fell in two of the last five years); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

From the filings

Starting free cash flow, US$ millions

Cash from operations minus capital spending in fiscal 2025.

Net cash, US$ millions

Cash and short-term investments minus debt and finance leases at January 31, 2026. Negative means net debt.

Diluted shares, millions

Weighted-average diluted shares in fiscal 2025.

Your assumptions

Start from

Fitted to Bath & Body Works's own revenue growth, as above. Cautious: growth of -2% then 0% a year, 2% after year 10, a 12% discount rate. Base: growth of 0% then 1% a year, 2.5% after year 10, a 11% discount rate. Optimistic: growth of 2% then 2.5% a year, 3% after year 10, a 10% discount rate.

Free cash flow growth, years 1 to 5 (% a year)

Free cash flow growth, years 6 to 10 (% a year)

Growth after year 10 (% a year)Long-run growth forever after year 10. Usually close to inflation, and always below the discount rate.

Discount rate (% a year)The yearly return an investor wants for the risk. A higher rate gives a lower value.

Value per share on these assumptions

—

Last close, October 26, 2026: $21.38
Value on these assumptions, against the last close: —

Cash flows in years 1 to 10, valued today: —
Everything after year 10, valued today: —
Plus net cash: —
Share of value from after year 10: —

Projected free cash flow

US$ billions. Each column is one year's projected free cash flow, split into what it is worth today and the part removed by discounting.

Value todayRemoved by discounting

How the value changes with two assumptions

Value per share in US$, with the growth rates above. The highlighted cell matches the current assumptions.

How the model works. Free cash flow grows at the first rate for five years and the second rate for five more, and each year is discounted at the discount rate. Everything after year 10 is valued as year-10 cash flow × (1 + growth after year 10) ÷ (discount rate − growth after year 10), discounted back ten years. Net cash is added and the total is divided by diluted shares. The result depends entirely on the assumptions. It is not a forecast, a price target or a recommendation. The last close is the consolidated US closing price, from Databento.

Price-to-earnings (P/E) method

Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.

Careful. Bath & Body Works' P/E today, 5.6×, is less than half the example multiple. A gap that wide usually means one of two things: its latest earnings include large one-off items, such as a tax benefit or a gain on a sale, or investors expect its earnings to fall. Either way the examples can mislead, so they aren't set against the share price. Check the earnings in its latest filings before using them.

Value per share on three example scenarios, from Bath & Body Works' earnings per share of $3.79 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 17.8×, the middle of Bath & Body Works' own P/E today, its peers' median and its sector's median (the Consumer Discretionary median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 12%, 11% and 10%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.

Earnings per share, US$

Diluted earnings per share over the four quarters to August 1, 2026, from the 10-Qs and 10-K.

P/E multiple

P/E today is the last close divided by the latest earnings per share, the four quarters' where available. Peers: Ulta Beauty, Chewy, Tractor Supply, Winmark.

Earnings growth in the years ahead (% a year) Starts at Bath & Body Works' revenue growth over the last 3 years, -1.2% a year, kept between 0% and 20%, as the base scenario does.

Earnings per share in the years ahead, US$

Year 1Year 2Year 3Year 4Year 5

Type your own estimate for any year; the years after it carry on at the growth rate.

Apply the multiple to earnings

A multiple on a future year's earnings gives the price then, brought back to today at the discount rate below.

Discount rate (% a year) The yearly return an investor wants for the risk, as in the cash flow model.

Value per share today at this multiple

—

Last close, October 26, 2026: $21.38
Value at this multiple, against the last close: —
Bath & Body Works' P/E at the last close: 5.6×

Company	Last close	Earnings per share	P/E today
ChewyCHWY	$21.90	$0.66	33.2×
WinmarkWINA	$282.29	$11.21	25.2×
Ulta BeautyULTA	$625.33	$27.42	22.8×
Tractor SupplyTSCO	$32.53	$1.92	16.9×
Bath & Body WorksBBWI	$21.38	$3.79	5.6×

How the P/E method works. Value per share is earnings per share times the multiple. On a future year's earnings, that gives the price in that year, which is brought back to today at the discount rate: price ÷ (1 + discount rate) for each year ahead. It is quick and easy to compare across companies, but it ignores debt and cash, and earnings can swing with one-off gains and charges, so a multiple says most about steady, profitable businesses. Like the cash flow model, the result depends entirely on the assumptions you choose. It is not a forecast, a price target or a recommendation.

Balance sheet

Fiscal year end	FY21	FY22	FY23	FY24	FY25
Cash and short-term investments	1,979	1,232	1,084	674	953
Debt incl. finance leases	4,854	4,862	4,388	3,884	3,892
Net debt (negative means net cash)	2,875	3,630	3,304	3,210	2,939
Net debt to EBITDA	1.2x	2.3x	2.1x	2.1x	2.1x
Debt to equity	—	—	—	—	—
Interest coverage	5.2x	4.0x	3.7x	4.1x	4.1x
Current ratio	2.3x	1.6x	1.6x	1.5x	1.3x
Quick ratio	1.8x	1.1x	1.1x	0.9x	0.8x

US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Insider trades

Over the 12 months between October 27, 2025 and October 26, 2026, 6 insiders bought $1.0 million of Bath & Body Works shares on the open market, and 1 insider sold $14.

Date	Insider	Trade	Shares	Price	Value	Filing
Oct 16, 2026	Sarah E NashDirector	Sold	1	$20.57	$14	Form 4
Nov 24, 2025	James Kevin SymancykDirector	Bought	22,500	$15.58	$350,550	Form 4
Nov 24, 2025	Sarah E NashDirector	Bought	10,000	$15.58	$155,800	Form 4
Nov 21, 2025	Steven E VoskuilDirector	Bought	20,000	$15.04	$300,800	Form 4
Nov 21, 2025	Stephen D SteinourDirector	Bought	6,700	$14.86	$99,562	Form 4
Nov 21, 2025	Francis HondalDirector	Bought	3,343	$15.00	$50,145	Form 4
Nov 21, 2025	Lucy BradyDirector	Bought	3,470	$14.40	$49,962	Form 4

Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Piotroski F-score

The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.

Test	FY23	FY24	FY25
Net income is positive	Pass	Pass	Pass
Cash from operations is positive	Pass	Pass	Pass
Return on assets rose	Pass	Fail	Fail
Cash from operations exceeds net income	Pass	Pass	Pass
Debt fell relative to assets	Pass	Pass	Fail
Current ratio rose	Fail	Fail	Fail
Share count didn't rise	Pass	Pass	Pass
Gross margin rose	Pass	Pass	Fail
Revenue rose relative to assets	Pass	Fail	Pass
F-score	8 of 9	6 of 9	5 of 9
Accruals ratio	−1.4%	−1.7%	−9.1%

The accruals ratio is net income minus cash from operations, over average total assets.

Compare

Put Bath & Body Works side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

Company	Year	Revenue growth	Operating margin	Free cash flow margin	Return on capital	Net debt to EBITDA	F-score	Compare
Bath & Body Works	FY25	−0.2%	15.4%	11.9%	47.5%	2.1x	5
Ulta Beauty	FY25	9.7%	12.4%	8.6%	55.8%	−0.2x	6	Compare
Chewy	FY25	6.2%	2.0%	4.5%	—	−2.3x	7	Compare
Tractor Supply	FY25	4.3%	9.4%	4.8%	28.5%	0.8x	6	Compare
Winmark	FY25	5.9%	63.4%	52.0%	—	0.4x	—	Compare

Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score above.

10 years of figures

Fiscal year	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Income statement
Revenue	12,574	12,632	13,237	5,405	6,434	7,882	7,560	7,429	7,307	7,291
Revenue growth	3.5%	0.5%	4.8%	−59.2%	19.0%	22.5%	−4.1%	−1.7%	−1.6%	−0.2%
Gross profit	5,125	4,959	4,899	2,387	3,096	3,855	3,255	3,236	3,234	3,189
Research and development	—	—	—	—	—	—	—	—	—	—
Operating income	2,003	1,728	1,237	1,040	1,604	2,009	1,376	1,285	1,266	1,126
Net income	1,158	983	644	−366	844	1,333	800	878	798	649
Diluted EPS (US$)	3.98	3.42	2.31	−1.32	3.00	4.88	3.43	3.84	3.61	3.11
Diluted shares (millions)	291	287	279	278	281	273	233	229	221	209
Cash flow
Cash from operations	1,990	1,406	1,377	1,236	2,039	1,492	1,144	954	886	1,102
Capital expenditure	990	707	629	458	228	270	328	298	226	237
Free cash flow	1,000	699	748	778	1,811	1,222	816	656	660	865
Dividends paid	1,268	686	666	332	83	120	186	182	177	167
Share buybacks	435	446	198	0	0	1,964	1,312	148	401	401
Acquisitions	33	0	0	0	0	0	0	0	0	0
Stock-based compensation	96	102	97	87	50	46	38	43	40	31
Balance sheet at fiscal year end
Cash and short-term investments	1,934	1,515	1,413	1,499	3,568	1,979	1,232	1,084	674	953
Debt incl. finance leases	5,700	5,707	5,766	5,508	6,399	4,854	4,862	4,388	3,884	3,892
Total assets	8,170	8,149	8,090	10,125	11,571	6,026	5,494	5,463	4,872	5,069
Total liabilities	8,897	8,900	8,955	11,620	12,232	7,543	7,699	7,089	6,255	6,348
Shareholders' equity	−729	−753	−869	−1,499	−662	−1,518	−2,206	−1,627	−1,385	−1,281
Margins and ratios
Gross margin	40.8%	39.3%	37.0%	44.2%	48.1%	48.9%	43.1%	43.6%	44.3%	43.7%
Operating margin	15.9%	13.7%	9.3%	19.2%	24.9%	25.5%	18.2%	17.3%	17.3%	15.4%
Net margin	9.2%	7.8%	4.9%	−6.8%	13.1%	16.9%	10.6%	11.8%	10.9%	8.9%
Free cash flow margin	8.0%	5.5%	5.7%	14.4%	28.1%	15.5%	10.8%	8.8%	9.0%	11.9%
Return on capital	45.9%	40.0%	26.8%	26.2%	52.8%	86.0%	75.1%	71.2%	56.1%	47.5%
Return on equity	—	—	—	—	—	—	—	—	—	—
Return on assets	13.9%	12.1%	7.9%	−4.0%	7.8%	15.2%	13.9%	16.0%	15.4%	13.1%
Net debt to EBITDA	1.5x	1.9x	2.4x	2.5x	1.3x	1.2x	2.3x	2.1x	2.1x	2.1x

US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)

Source: Bath & Body Works' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Bath & Body Works.